Alzamend Neuro Inc (ALZN) Return on Investment ROI from the first quarter of 2026 to first quarter of 2026 and for the year 2026, average high and low, overall ranking from Jul 31 2026 to Jul 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alzamend Neuro Inc   (NASDAQ: ALZN)


Alzamend Neuro Inc's ROI from its first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Alzamend Neuro Inc's ROI in the first quarter of 2026?
Alzamend Neuro Inc recorded a cumulative net loss of $-9 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -234.34%.

Within the Healthcare sector 733 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2026 from 3736 to 4864.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jul 31 2026)
I. Quarter		 (Apr 30 2026)
IV. Quarter		 (Jan 31 2026)
III. Quarter		 (Oct 31 2025)
II. Quarter		 (Jul 31 2025)
I. Quarter
Y / Y Investment Change TTM 3.85 % 33.61 % 130.32 % 38.27 % 136.17 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 6 1 5 4 5
Return On Investment (TTM) -234.34 % -232.88 % -166.92 % -180.83 % -182.82 %
ALZN's Overall Ranking # 4864 # 3736 # 3727 # 3624 #
Seq. Investment Change TTM 3.05 % -17.61 % 27.74 % -4.24 % 32.57 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -9 -9 -8 -6 -7

ALZN Company Profile >> Back to ALZN Roi Comparisons >> See Annual ALZN Return On Investment



Return On Investment ALZN's Ranking
Within: No.
Industry # 348
Sector # 734
Overall # 4864

Return On Investment Statistics
High Average Low
-105.65 %
-817.73 %
-8704.98 %
(Jul 31 2022)   (Apr 30 2024)







Financial Statements
Alzamend Neuro Inc's I. Quarter Investments $ 6 Millions ALZN's Balance sheet
Alzamend Neuro Inc's I. Quarter Income $ -3 Millions Quarterly ALZN's Income Statement
ALZN's Income by Division See ALZN's Income by Division


ALZN Annual Return On Investment (Apr 30 2026)
2026		 (Apr 30 2025)
2025		 (Apr 30 2024)
2024		 (Apr 30 2023)
2023		 (Apr 30 2022)
2022
Total Investments in Millions 2 5 1 3 13
Y / Y Investment Growth -54.83 % 628.8 % -79.26 % -77.19 % 1524.87 %
Net Income in Millions 9 -5 -10 -15 -12
Y / Y Net Income Growth - - - - -
Annual Return On Investment 423.21 % -110.91 % -1575.04 % -488.53 % -92.59 %


Annual Roi Comment
In the fiscal year 2026 ROI improved to 423.21 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ALZN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ALZN's Competitors
Subscribers only: Roi for Alzamend Neuro Inc's Suppliers
Subscribers only: Return On Investment for ALZN's Customers

Other Ratios
ALZN's Roa ALZN's Inventory Turnover Ratio ALZN's Growth Rates ALZN's Dividend Statistics
ALZN's Profitability Ratios ALZN's Asset Turnover Ratio ALZN's Dividend Growth
ALZN's Roe ALZN's Valuation Ratios ALZN's Financial Strength Ratios ALZN's Dividend Payout Ratio



Companies with similar Return On Investment at Jul 31 2026, within Healthcare Sector ROI

Date modified: 2026-09-18T15:21:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.